The latest health news
Did we take off our masks too soon? Can Democrats pass a drug pricing bill? And do pharma CEOs get weapons training? We cover all that and more this week …
Read More
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox. It’s official: Medicare …
Read More
In his first budget, President Biden set aggressive health goals. “Let’s end cancer as we know it,” he said to rousing applause in a speech to Congress. “It’s within our …
Read More
When Eli Lilly announced in 2017 that it would stop producing quinidine, it was the only medication approved for severe malaria treatment in the U.S. As quinidine supplies dwindled, the …
Read More
STAT’s tool allows users to visualize individual drug companies’ corporate PAC spending, mapped geographically based on each company’s U.S. headquarters, as listed on its website. WASHINGTON — Seventy-two senators and …
Read More
Major pharmaceutical companies and trade groups helped fund the campaigns of more than 2,400 state legislators nationwide in the 2020 election. Lawmakers who don’t appear on the map did not …
Read More
When Amber Freed heard in 2020 that a drug might help save her young child from a rare, progressive form of epilepsy, she was ecstatic. The news came just in …
Read More
A key element in the long-simmering debate on reining in drug prices in the United States is how to ensure that prices are affordable, represent a sufficient reward to industry …
Read More
Does President Biden really care about drug prices? Is Sputnik V falling out of orbit? And why’s it so hard to find pipette tips? We cover all that and more …
Read More